Literature DB >> 12765196

Anti-invasion and anti-angiogenesis effect of taxol and camptothecin on melanoma cells.

Fang Wang1, Yu Cao, Hong-Yan Liu, Shao-Feng Xu, Rui Han.   

Abstract

Two highly invasive melanoma cell lines B16BL6 and B16F10 were used to investigate the anti-invasion and antiangiogenesis action of taxol and camptothecin (CPT). The adhesion of melanoma cells was tested by optical absorbance at 545 nm. The invasive activity of these cells was tested in a transwell chamber assay. The cell migration within a 3D collagen matrix was recorded with a time-lapse video recorder and analyzed by computer-assisted cell tracking. Gelatin zymography was used to study the metalloproteinase activity. The chicken chorioallantoic membrane (CAM) model was used to study the anti-angiogenesis effect of the two drugs. The results demonstrated that both taxol and CPT could inhibit the migration of B16F10 cells, and inhibit the adhesion of B16F10 to fibronectin and laminin. They can reduce the metalloproteinase secretion of HT1080 and exhibit the antiangiogenesis effect in the CAM model. Taxol showed a highly anti-invasion effect on B16BL6 cells while CPT did not exhibit such an effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12765196     DOI: 10.1080/1028602021000054973

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  3 in total

1.  [Isolation of mitochondrial DNA binding proteins which are specific for maize cox1 promoter].

Authors:  V I Tarasenko; I Iu Subota; V F Kobzev; Iu M Konstantinov
Journal:  Mol Biol (Mosk)       Date:  2005 May-Jun

Review 2.  Programmed cell death, redox imbalance, and cancer therapeutics.

Authors:  Xiaofeng Dai; Danjun Wang; Jianying Zhang
Journal:  Apoptosis       Date:  2021-07-08       Impact factor: 4.677

Review 3.  The pharmacological bases of the antiangiogenic activity of paclitaxel.

Authors:  Guido Bocci; Antonello Di Paolo; Romano Danesi
Journal:  Angiogenesis       Date:  2013-02-07       Impact factor: 9.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.